Enteric Disease Testing Market Report 2026

Enteric Disease Testing Market Overview

• Enteric Disease Testing market size has reached to $4.86 billion in 2025 • Expected to grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: The Increasing Cases Of Diarrhea And Hemolytic Urea Syndrome (HUS) Driving Growth In The Enteric Disease Testing Market • Market Trend: Advancements in Enteric Disease Testing: The Role of Laboratory Tools in Enhancing Diagnostic Accuracy • North America was the largest region in 2025 and Europe is the fastest growing region.

What Is Covered Under Enteric Disease Testing Market?

Enteric disease testing diagnoses enteric diseases such as food and water-borne diseases. Microorganisms such as viruses, bacteria, and parasites, cause enteric diseases that affect intestinal health. These pathogens can be contracted by contaminated food and drink and by coming into contact with the excrement of an infected animal or person. Abdominal cramping, vomiting, nausea, and anorexia are common symptoms of enteric disorders, which can cause the body to lose fluids and nutrients. Enteric disease testing involves tests and technologies such as diagnostic assays and rapid tests, testing of stool specimens, complete blood count (CBC) test, blood culture test, urine test, antibody test, and bone marrow test for the diagnosis of the enteric disease-causing agent. The main disease types of enteric disease testing are bacterial enteric disease, parasitic enteric disease, viral enteric disease, and others. Bacteria are a type of disease-causing microorganism that can be found almost anywhere, including in soil and water. Salmonella, campylobacter, shigella, clostridium difficile, and diverse strains of E. coli are examples of enteric bacterial pathogens. The different technologies include traditional, rapid, convenience-based, polymerase chain reaction (PCR), immunoassay, chromatography, spectrometry, and others. The tests are used by hospitals, research centers, clinics, and others.

What Is The Enteric Disease Testing Market Growth Forecast?

The enteric disease testing market size is expected to see strong growth in the next few years. It will grow to $6.62 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rapid test adoption, molecular diagnostic growth, outbreak preparedness initiatives, sanitation awareness, healthcare access expansion. Major trends in the forecast period include rising incidence of foodborne diseases, increased demand for rapid diagnostic tests, expansion of stool-based diagnostic methods, growth in public health surveillance testing, focus on early pathogen identification.

Global Enteric Disease Testing Market Segmentation

1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types 2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (Pcr), Immunoassay, Chromatography And Spectrometry, Other Technologies 3) By Application: Hospitals, Research Centers, Clinics, Other Applications Subsegments: 1) By Bacterial Enteric Disease: Salmonella, Escherichia Coli (E. Coli), Shigella, Campylobacter, Clostridium Difficile (C. Diff) 2) By Parasitic Enteric Disease: Giardia Lamblia, Entamoeba Histolytica, Cryptosporidium, Trichinella Spiralis 3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus 4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea

What Is The Driver Of The Enteric Disease Testing Market?

The increasing cases of diarrhea and hemolytic urea syndrome (HUS) are expected to propel the growth of the enteric disease testing market going forward. The major cause of diarrheal disease cases is the consumption of contaminated food and water. The disorder hemolytic urea syndrome (HUS) affects the blood and blood vessels and is most common in children with diarrhea. Diarrheal disease and HUS are among the leading causes of death in children under five. The increasing cases of diarrhea and hemolysis will need testing solutions, raising the demand for enteric disease testing solutions. For instance, in March 2024, according to the World Health Organization, a Switzerland-based national agency reported that each year diarrhea kills around 443 832 children under 5 and an additional 50 851 children aged 5 to 9 years. Further, there are nearly 1.7 billion cases of childhood diarrheal disease every year globally. Thus, the increasing incidences of enteric diseases will drive the growth of the enteric disease testing industry.

Key Players In The Global Enteric Disease Testing Market

Major companies operating in the enteric disease testing market are Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

Global Enteric Disease Testing Market Trends and Insights

Major companies operating in the enteric disease testing market are focusing on developing advanced diagnostic solutions, such as laboratory tools, to enhance diagnostic accuracy and improve patient outcomes. Laboratory tools are specialized instruments and equipment used in scientific and medical laboratories to perform tests, analyze samples, and generate accurate data for diagnostics. These tools are essential for enhancing the precision of diagnostic procedures and facilitating research in various fields, including enteric disease testing. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a China-based biotechnology company, launched real-time PCR kits specifically designed for the diagnosis of gastrointestinal infectious diseases. offer high sensitivity and specificity, enabling the accurate detection of low amounts of nucleic acids in various samples. They also allow for rapid analysis, significantly reducing processing times and increasing throughput in diagnostic and research applications.

What Are Latest Mergers And Acquisitions In The Enteric Disease Testing Market?

In June 2023, Avacta Group plc, a UK-based provider of diagnostic and life-science technologies, acquired Coris BioConcept SRL for $0.009 billion (£7.4 million) upfront, with an additional earn-out of up to $0.004 billion (£3.0 million). Through this acquisition, Avacta aims to expand its enteric disease testing capabilities by integrating Coris BioConcept’s rapid lateral-flow and immunochromatographic diagnostic kits for gastrointestinal pathogens, including Giardia, Cryptosporidium, Clostridioides difficile, Helicobacter pylori, rotavirus, and adenovirus. Coris BioConcept SRL is a Belgium-based diagnostic manufacturer that provides rapid test kits for gastroenteric infections, respiratory pathogens, and antimicrobial-resistance markers.

Regional Outlook

North America was the largest region in the enteric disease testing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Enteric Disease Testing Market?

The enteric disease testing market includes revenues earned by entities by amebiasis, campylobacteriosis, cryptosporidiosis, and cyclosporiasis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Enteric Disease Testing Market Report 2026?

The enteric disease testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the enteric disease testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.